688426 Stock Overview
Engages in the research and development, production, and sale of biological products in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Jiangsu CoWin Biotech Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥28.34 |
| 52 Week High | CN¥31.26 |
| 52 Week Low | CN¥14.02 |
| Beta | 0.66 |
| 1 Month Change | 29.35% |
| 3 Month Change | 30.42% |
| 1 Year Change | -5.03% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -22.04% |
Recent News & Updates
Shareholder Returns
| 688426 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | 5.9% | -5.5% | -4.8% |
| 1Y | -5.0% | -24.1% | 5.0% |
Return vs Industry: 688426 exceeded the CN Biotechs industry which returned -24.1% over the past year.
Return vs Market: 688426 underperformed the CN Market which returned 5% over the past year.
Price Volatility
| 688426 volatility | |
|---|---|
| 688426 Average Weekly Movement | 9.2% |
| Biotechs Industry Average Movement | 7.8% |
| Market Average Movement | 8.1% |
| 10% most volatile stocks in CN Market | 12.2% |
| 10% least volatile stocks in CN Market | 5.1% |
Stable Share Price: 688426 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 688426's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 693 | n/a | www.cwbio.com |
Jiangsu CoWin Biotech Co., Ltd. engages in the research and development, production, and sale of biological products in China. The company provides molecular diagnostic raw material enzymes, nucleic acid collection and protection agents, nucleic acid extraction and purification kits, molecular diagnostic testing reagents, etc. It also offers medical device products, nucleic acid collection and protection, PCR, RT-PCR, and qPCR products, molecular diagnosis, isothermal amplification, nucleic acid mass spectrometry, next generation sequencing, nucleic acid extraction and purification, marker clone transfection, antibody, protein detection products, and scientific research instruments. The company was founded in 2010 and is headquartered in Taizhou, China.
Jiangsu CoWin Biotech Co., Ltd. Fundamentals Summary
| 688426 fundamental statistics | |
|---|---|
| Market cap | CN¥3.32b |
| Earnings (TTM) | -CN¥144.51m |
| Revenue (TTM) | CN¥118.17m |
26.7x
P/S Ratio-21.8x
P/E RatioIs 688426 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688426 income statement (TTM) | |
|---|---|
| Revenue | CN¥118.17m |
| Cost of Revenue | CN¥59.18m |
| Gross Profit | CN¥58.99m |
| Other Expenses | CN¥203.51m |
| Earnings | -CN¥144.51m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Apr 25, 2025
| Earnings per share (EPS) | -1.30 |
| Gross Margin | 49.92% |
| Net Profit Margin | -122.29% |
| Debt/Equity Ratio | 0% |
How did 688426 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/03 08:28 |
| End of Day Share Price | 2025/01/03 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Jiangsu CoWin Biotech Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Feifei Xu | China Merchants Securities Co. Ltd. |